Taysha Gene Therapies, Inc.

TSHA·NASDAQ·$5.59Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/19/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report06/25/26 8-KCurrent report06/22/26 8-KCurrent report06/02/26 8-KCurrent report05/06/26

Prospectuses and Registrations

424B5Prospectus supplement06/25/26 424B5Prospectus supplement06/24/26 S-8Registration of securities for employees01/06/26 S-3ASRAutomatic shelf registration11/04/25 424B5Prospectus supplement05/29/25

Proxies

DEF 14ADefinitive proxy04/22/26 DEFA14AAdditional proxy materials04/22/26 DEFR14ADefinitive proxy (revised)05/09/25 DEF 14ADefinitive proxy04/21/25 DEFA14AAdditional proxy materials04/21/25

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 144Proposed sale of securities07/10/26 Form 4Insider transaction07/10/26 Form 4Insider transaction06/02/26 Form 4Insider transaction06/02/26

Other

ARSAnnual report to shareholders04/22/26 ARSAnnual report to shareholders04/21/25 CORRESPCorrespondence with the SEC12/20/24 EFFECTRequest for effectiveness12/20/24 CORRESPCorrespondence with the SEC12/19/24